07-01-2026 22:03 via medpagetoday.com

Will Progress on Protecting Young Kids From RSV Be Reversed?

(MedPage Today) -- Infectious disease experts are dismayed that the monoclonal antibody against respiratory syncytial virus (RSV) for infants, widely considered a crucial advance in public health, has been downgraded on the childhood immunization...

Some Flu Measures Decline, but It's Not Clear This Severe Season Has Peaked

Lawmakers Aim to Block Expansion of Prior Auth in Traditional Medicare

U.S. Guidelines Endorse At-Home Cervical Cancer Screening

Kate Middleton's Chemo; SGLT2 Inhibitors and Prostate Cancer; New Myeloma Guidance

Alzheimer's Risk May Be Driven by a Single Gene

Addressing Patient Emotions in Vaccine Conversations

Surgery Beats GLP-1 Drugs for Fat Loss, Muscle Retention, Study Suggests

Opportunistic Cholesterol Gene Screens: Good in Theory Only?

FDA Moves to 'Get Out of the Way' of Wearables, AI in the Clinic

Gang Violence Forces Doctors Without Borders to Suspend Services at Haiti Clinic

Health Myths Debunked; Astronaut's Medical Crisis; GLP-1 for Psoriatic Arthritis

I Deserve to Feel Safe Where I Train and Learn

House Passes Bill to Extend Healthcare Subsidies in Defiance of GOP Leaders

CAR7 Gene Therapy Shows Promise in T-Cell ALL

Desktop versie

Will Progress on Protecting Young Kids From RSV Be Reversed?

Medical news